search
Back to results

Opioid Treatment and Peer Recovery Support (JCOIN)

Primary Purpose

Opioid-use Disorder

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Core Intervention
Peer Support Specialists (PSS)
Treatment as Usual (TAU)
Sponsored by
Brown University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Opioid-use Disorder focused on measuring Opioid Use, Medications for Opioid Use

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Community Provider Staff: Any front-line treatment provider at an agency participating in this study who: (a) provides support to MOUD clients, (b) has an active caseload including some individuals on probation, (c) has been employed by the community treatment agency at least 3 months, and (d) willing to commit to 12 months to the project.
  • Probation/Parole Staff: Any probation officer (PO) at an agency participating in this study who (a) has an active caseload, (b) has been employed at the probation agency at least 6 months, and (c) is willing to commit to 12 months to the project.
  • Individuals on Probation: (a) 18 years or older, (b) committed to probation within 90 days prior to study enrollment, (c) English speaking, (d) diagnosed with OUD, (e) have stable method of contact in community

Exclusion Criteria:

  • Individuals on Probation: Currently incarcerated or in a court-mandated inpatient treatment.

Sites / Locations

  • Duke UniversityRecruiting
  • Temple UniversityRecruiting
  • Brown UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Active Comparator

Arm Label

Implementation Core

Randomized Trial of Peer Support Specialist Model

Randomized to Treatment as Usual

Arm Description

During baseline Exploration, staff organizational surveys are collected. During Preparation, staff focus groups conduct needs assessment with system mapping of linkage points for screening, assessment, and referral, and the agencies/staff involved in these activities. During Implementation, sites use facilitated local change teams (LCT) provided with a core set implementation strategies to facilitate linkages between probation agencies and local community treatment providers. The LCTs identify barriers to change, approaches to overcome barriers, do goal selection using SMART (specific, measurable, achievable, relevant, timely) goals and evidence for medications, address stigma, and clarify needs/expectations/roles of probation officers and treatment providers, then choose and implement goals and strategies. Sustainability Phase: Facilitators work with LCTs for 12 months using a written action plan based on goal selection.

After Core implementation is complete, half of adult participants in probation who consent will be randomly assigned to a Peer Support Specialist (PSS) condition. PSS are assigned to adults diagnosed with OUD within 6 months of entry into probation, in addition to treatment as usual. PSS establish linkages to community providers (medical, mental health, substance use treatment); educate about recovery support services, transportation assistance, MOUD; provide experiential, non-clinical support to individuals with SUD; share skills, offer support for setting goals and navigating the recovery process); and provide referrals and support for treatment, housing, employment, drug court, and probation.

After Core Implementation is complete, half of adult participants in probation who consent will be randomly assigned to continue with usual care.

Outcomes

Primary Outcome Measures

Individual-Level Experimental (Period 2) Outcome: Engagement in MOUD
Calculated from self-report survey of being enrolled in MOUD (yes or no) at each assessment.
Program-Level Implementation Outcome: Engagement in MOUD
MOUD engagement (primary implementation outcome) is defined as enrollment in MOUD treatment program, or filling a prescription for buprenorphine from a provider (in not on MOUD at time of recruitment), or remaining in MOUD treatment (if already on MOUD when recruited or at previous follow-up), coded dichotomously. Number of clients in probation enrolled in MOUD is tracked via medical and probation records.

Secondary Outcome Measures

Detainment during Assessment Period (Individual-Level Experimental (Period 2) Outcome)
Calculated from probation records: Number of days detained during the assessment period
Opioid Use (Individual-Level Experimental (Period 2) Outcome)
Calculated from self-report surveys and urine screens: any opioid use
Non-Fatal Overdose Events (Individual-Level Experimental (Period 2) Outcome)
Calculated from treatment agency records: number of reports of medical treatment or death due to overdose events.
Staff MOUD Knowledge and Attitudes (Program-Level Implementation Outcome)
Extent of staff knowledge about and attitudes towards MOUD, commitment and efficacy, readiness for change, using Medications Opinion Survey.
Organizational Readiness for Change (Program-Level Implementation Outcome)
Measures of organizational climate, functioning, innovation support, leadership, and staff attributes were adapted from the Evidence-Based Practices Attitudes Scale (Aarons, 2004), Survey of Organizational Functioning (IBR, 2005), and Organizational Readiness for Change (IBR, 2009). Organizational linkages for collaboration and coordination between correctional and treatment agency dyads, using the Inter-Organizational Relationships (IOR) Survey.
Input Costs: PSS time (Program-Level Implementation Outcome)
PSS logs will be used to record the time PSSs spend with each participant (hours and minutes). Data analyses will convert these to dollar costs per participant using information from the Bureau of Labor Statistics.
Input Costs: Medical Usage (Program-Level Implementation Outcome)
Participant surveys will be sued to record number of visits to each type of medical provider during the study. Data analyses will convert these to dollar costs using Medicare fee-for-service information.
Outcome Costs (Program-Level Implementation Outcome)
Participant surveys will be used to record number of days in jail during the follow-up period. Analyses will convert these to dollar costs using government information.

Full Information

First Posted
May 25, 2021
Last Updated
September 26, 2023
Sponsor
Brown University
Collaborators
University of North Carolina, Chapel Hill, Temple University, University of Rhode Island, The Miriam Hospital, National Institute on Drug Abuse (NIDA), CODAC Behavioral Healthcare, Duke University
search

1. Study Identification

Unique Protocol Identification Number
NCT04978168
Brief Title
Opioid Treatment and Peer Recovery Support
Acronym
JCOIN
Official Title
Using Implementation Interventions and Peer Recovery Support to Improve Opioid Treatment Outcomes in Community Supervision
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 2, 2021 (Actual)
Primary Completion Date
April 30, 2025 (Anticipated)
Study Completion Date
April 30, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Brown University
Collaborators
University of North Carolina, Chapel Hill, Temple University, University of Rhode Island, The Miriam Hospital, National Institute on Drug Abuse (NIDA), CODAC Behavioral Healthcare, Duke University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Determine whether a facilitated local change team intervention improves a probation organization's client-level medication for opioid use disorder (MOUD) outcomes and implementation outcomes relative to baseline across multiple sites. Determine whether client-level outcomes are further enhanced by the introduction of Peer Support Services.
Detailed Description
Background: The purpose is to determine whether a facilitated local change team (LCT) intervention improves linkage to medication for opioid use disorder (MOUD) and implementation outcomes, and whether participant-level outcomes are further enhanced by the use of Peer Support Specialists (PSS). Methods/Design: This Type 1 hybrid implementation-effectiveness study involves a pre-post design (implementation study) followed by a randomized trail of PSS (effectiveness study). The study is conducted at 7 performance sites in 3 states. Phase 1 (Core Implementation Study): The Exploration, Preparation, Implementation, Sustainability (EPIS) framework is used to guide system-change through facilitated LCTs consisting of probation and community treatment staff who are given a core set of implementation strategies which are used to conduct a needs assessment and set goals. The overall objective is to improve linkage to the continuum of evidence-based care for justice-involved individuals with opioid use disorder (OUD). Organizational (program-level) and staff survey are collected at the end of each EPIS stage (baseline Exploration, end of Preparation, end of Implementation, and 12 months [Sustainability]). Implementation outcomes: Organizational engagement in MOUD (primary), plus changes in staff knowledge/attitudes and organizational outcomes (secondary). Phase 2 (Effectiveness Study of PSS): After completing implementation, 580 adults on probation are randomized to receive PSS vs. treatment as usual (TAU), with assessments at baseline, 3, 6, and 12 months. This trial tests whether having a trained peer improves clinical outcomes beyond effects of Core Implementation. Implementation program-level outcomes include organizational engagement in MOUD use (primary outcome); changes in staff knowledge and attitudes about MOUD, commitment and efficacy, readiness for change; organizational attitudes for change, commitment and efficacy (secondary outcomes). Client-level effectiveness outcomes include participant engagement in MOUD (primary outcome), probation revocation, illicit opioid use, and overdoses (secondary outcomes). Other aims include identifying barriers and facilitators, and cost-benefit analysis of PSS. Primary Research Questions: The primary aim is to test the effectiveness of PSS compared to TAU (agency approach after implementation) on outcomes of individuals on probation: Engagement in MOUD (primary effectiveness outcome), probation revocation (secondary), illicit opioid use (secondary), and overdose (tertiary). The second aim is to test the effectiveness of EPIS-based Core Implementation Intervention relative to baseline on engagement in MOUD (primary implementation outcome). The third aim is to test the effects of the EPIS implementation strategies relative to baseline on program-level (organizational and staff-level) outcomes. The fourth aim is to conduct a cost-benefit analysis of implementing PSS compared to TAU. The fifth aim is to identify organizational and staff barriers and facilitators to intervention implementation by conducting qualitative interviews with key probation and community treatment stakeholders who are managing and delivering the MOUD program.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Opioid-use Disorder
Keywords
Opioid Use, Medications for Opioid Use

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A Type 1 hybrid implementation-effectiveness study conducted in two phases. The first recruits as staff/leaders from probation agencies and community treatment agencies. The second phase (which starts after the implementation in the first period is completed) recruits adults on probation and staff of probation agencies. The Core Implementation study (first phase) involves a pre-post design. The effectiveness study (second phase) uses randomized parallel assignment with two arms. The initial Core Implementation study involved four phases: Exploration (baseline), Preparation, Implementation, Sustainability (6- and 12-month follow-ups). The subsequent Effectiveness study starts after the Implementation phase is completed, with its own baseline data and follow-ups up to 12 months.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
580 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Implementation Core
Arm Type
Experimental
Arm Description
During baseline Exploration, staff organizational surveys are collected. During Preparation, staff focus groups conduct needs assessment with system mapping of linkage points for screening, assessment, and referral, and the agencies/staff involved in these activities. During Implementation, sites use facilitated local change teams (LCT) provided with a core set implementation strategies to facilitate linkages between probation agencies and local community treatment providers. The LCTs identify barriers to change, approaches to overcome barriers, do goal selection using SMART (specific, measurable, achievable, relevant, timely) goals and evidence for medications, address stigma, and clarify needs/expectations/roles of probation officers and treatment providers, then choose and implement goals and strategies. Sustainability Phase: Facilitators work with LCTs for 12 months using a written action plan based on goal selection.
Arm Title
Randomized Trial of Peer Support Specialist Model
Arm Type
Experimental
Arm Description
After Core implementation is complete, half of adult participants in probation who consent will be randomly assigned to a Peer Support Specialist (PSS) condition. PSS are assigned to adults diagnosed with OUD within 6 months of entry into probation, in addition to treatment as usual. PSS establish linkages to community providers (medical, mental health, substance use treatment); educate about recovery support services, transportation assistance, MOUD; provide experiential, non-clinical support to individuals with SUD; share skills, offer support for setting goals and navigating the recovery process); and provide referrals and support for treatment, housing, employment, drug court, and probation.
Arm Title
Randomized to Treatment as Usual
Arm Type
Active Comparator
Arm Description
After Core Implementation is complete, half of adult participants in probation who consent will be randomly assigned to continue with usual care.
Intervention Type
Behavioral
Intervention Name(s)
Core Intervention
Intervention Description
Staff are provided with a core set of implementation strategies to facilitate interorganizational linkages between probation agencies and local community treatment providers.
Intervention Type
Behavioral
Intervention Name(s)
Peer Support Specialists (PSS)
Intervention Description
Participants randomized to PSS will meet with a PSS for 12 months. Contact scheduled is flexible and based on the participant's needs and wants, plus written guidance for PSS-participant interactions.
Intervention Type
Behavioral
Intervention Name(s)
Treatment as Usual (TAU)
Intervention Description
Participants randomized to TAU will receive the services that will be offered at the time the Core Implementation intervention is completed.
Primary Outcome Measure Information:
Title
Individual-Level Experimental (Period 2) Outcome: Engagement in MOUD
Description
Calculated from self-report survey of being enrolled in MOUD (yes or no) at each assessment.
Time Frame
52 weeks
Title
Program-Level Implementation Outcome: Engagement in MOUD
Description
MOUD engagement (primary implementation outcome) is defined as enrollment in MOUD treatment program, or filling a prescription for buprenorphine from a provider (in not on MOUD at time of recruitment), or remaining in MOUD treatment (if already on MOUD when recruited or at previous follow-up), coded dichotomously. Number of clients in probation enrolled in MOUD is tracked via medical and probation records.
Time Frame
52 weeks
Secondary Outcome Measure Information:
Title
Detainment during Assessment Period (Individual-Level Experimental (Period 2) Outcome)
Description
Calculated from probation records: Number of days detained during the assessment period
Time Frame
52 weeks
Title
Opioid Use (Individual-Level Experimental (Period 2) Outcome)
Description
Calculated from self-report surveys and urine screens: any opioid use
Time Frame
52 weeks
Title
Non-Fatal Overdose Events (Individual-Level Experimental (Period 2) Outcome)
Description
Calculated from treatment agency records: number of reports of medical treatment or death due to overdose events.
Time Frame
52 weeks
Title
Staff MOUD Knowledge and Attitudes (Program-Level Implementation Outcome)
Description
Extent of staff knowledge about and attitudes towards MOUD, commitment and efficacy, readiness for change, using Medications Opinion Survey.
Time Frame
52 weeks
Title
Organizational Readiness for Change (Program-Level Implementation Outcome)
Description
Measures of organizational climate, functioning, innovation support, leadership, and staff attributes were adapted from the Evidence-Based Practices Attitudes Scale (Aarons, 2004), Survey of Organizational Functioning (IBR, 2005), and Organizational Readiness for Change (IBR, 2009). Organizational linkages for collaboration and coordination between correctional and treatment agency dyads, using the Inter-Organizational Relationships (IOR) Survey.
Time Frame
52 weeks
Title
Input Costs: PSS time (Program-Level Implementation Outcome)
Description
PSS logs will be used to record the time PSSs spend with each participant (hours and minutes). Data analyses will convert these to dollar costs per participant using information from the Bureau of Labor Statistics.
Time Frame
52 weeks
Title
Input Costs: Medical Usage (Program-Level Implementation Outcome)
Description
Participant surveys will be sued to record number of visits to each type of medical provider during the study. Data analyses will convert these to dollar costs using Medicare fee-for-service information.
Time Frame
52 weeks
Title
Outcome Costs (Program-Level Implementation Outcome)
Description
Participant surveys will be used to record number of days in jail during the follow-up period. Analyses will convert these to dollar costs using government information.
Time Frame
52 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Community Provider Staff: Any front-line treatment provider at an agency participating in this study who: (a) provides support to MOUD clients, (b) has an active caseload including some individuals on probation, and (c) willing to commit to 12 months to the project. Probation/Parole Staff: Any probation officer (PO) at an agency participating in this study who (a) has an active caseload, and (b) is willing to commit to 12 months to the project. Individuals on Probation: (a) 18 years or older, (b) committed to probation within 90 days prior to study enrollment, (c) English speaking, (d) diagnosed with OUD, (e) have stable method of contact in community Exclusion Criteria: Individuals on Probation: Currently incarcerated or in a court-mandated inpatient treatment.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rosemarie A Martin, PhD
Phone
401-863-6656
Email
Rosemarie_Martin@brown.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Jennifer Duff
Phone
401-863-6667
Email
Jennifer_Duff@brown.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rosemarie A Martin, PhD
Organizational Affiliation
Brown University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Damaris J Rohsenow, PhD
Organizational Affiliation
Brown University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Lauren Brinkley-Rubinstein, PhD
Organizational Affiliation
Duke University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Steven Belenko, PhD
Organizational Affiliation
Temple University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Lynda Stein, PhD
Organizational Affiliation
University of Rhode Island
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Josiah Rich, MD
Organizational Affiliation
The Miriam Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Duke University
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27708
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lauren Brinkley-Rubinstein, PhD
Phone
919-962-1136
Email
lauren.br@duke.edu
First Name & Middle Initial & Last Name & Degree
Alice Cates
Email
alice.cates@duke.edu
Facility Name
Temple University
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19122
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Steven Belenko, PhD
Phone
215-204-2211
Email
sbelenko@temple.edu
First Name & Middle Initial & Last Name & Degree
Doris Weiland
Email
doris.weiland@temple.edu
Facility Name
Brown University
City
Providence
State/Province
Rhode Island
ZIP/Postal Code
02912
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rosemarie A Martin, PhD
Phone
401-863-6656
Email
Rosemarie_Martin@brown.edu
First Name & Middle Initial & Last Name & Degree
Jennifer Duff
Phone
4018636667
Email
Jennifer_Duff@brown.edu

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The coordinating center is charged with creating de-identified versions of agency staff and probation individual level data available at the end of the study.
IPD Sharing Time Frame
The data will become available after the results of the primary study analyses have been accepted for publication. The data will be available for five years.
IPD Sharing Access Criteria
De-identified data will be shared with the Methodology and Advanced Analytics Resource Center (MAARC) of JCOIN and with qualified researchers on request to the MAARC.

Learn more about this trial

Opioid Treatment and Peer Recovery Support

We'll reach out to this number within 24 hrs